For people with depression that hasn’t responded to other treatments, a nasal spray called esketamine helps a little bit — and it works about as well as adding another type of psychiatric medication.
Claim Language
Language Strength
probability
Uses probability language (may, likely, can)
The claim uses 'is modest' and 'comparable to', which indicate a probabilistic or relative assessment rather than a definitive or absolute statement. These terms suggest likelihood or degree of effect without asserting certainty.
Context Details
Domain
medicine
Population
human
Subject
intranasal esketamine
Action
is
Target
modest and comparable to augmentation with atypical antipsychotics in efficacy for treatment-resistant depression
Intervention Details
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.
Evidence from Studies
Supporting (1)
Esketamine Treatment for Depression in Adults: A PRISMA Systematic Review and Meta-Analysis.
This study found that the nasal spray esketamine helps a little bit with severe depression that doesn’t respond to other treatments — and it helps about as much as adding certain antipsychotic pills, which is exactly what the claim says.